Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070705 · ClinicalTrials.gov registry record · NA
DCE MRI in Patients With Pancreatic Cancer
A NA study, sponsored by OHSU Knight Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT02070705 is a NA study that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 77 participants.
The verdict
NCT02070705, a NA study, was terminated before completion, sponsored by OHSU Knight Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
This clinical trial studies an imaging technique known as dynamic contrast enhanced magnetic resonance imaging (DCE MRI) in identifying the presence of pancreatic cancer. DCE MRI is a procedure that takes detailed pictures of functional and structural properties inside the body using magnetic field imaging. These images may better characterize pancreatic cancer in patients at high risk or in patients who may have undergone chemotherapy for pancreatic cancer.
Interventions
- DRUG Ferumoxytol
- PROCEDURE Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2014-01-31 |
| Est. Completion | 2024-08-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02070705
The ClinicalTrials.gov registry entry for NCT02070705 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ferumoxytol is the first listed.
NCT02070705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02070705 about?
NCT02070705 is a clinical study titled "DCE MRI in Patients With Pancreatic Cancer". This clinical trial studies an imaging technique known as dynamic contrast enhanced magnetic resonance imaging (DCE MRI) in identifying the presence of pancreatic cancer. DCE MRI is a procedure that takes detailed pictures of functional and structural properties inside the body using magnetic field ...
What is the current status of trial NCT02070705?
This trial is currently terminated. It is a NA study. The enrollment target is 77 participants. The study started on 2014-01-31. Estimated completion is 2024-08-07.
What interventions are being tested in trial NCT02070705?
The interventions under investigation include: Ferumoxytol (DRUG), Dynamic Contrast-Enhanced Magnetic Resonance Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT02070705?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.